InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by NEWELL WILLIAM J, Chairman & CEO. Director active across 1 company, notably Sutro Biopharma, INC.. Cumulatively, 8 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €71k. History available since 1 July 2021. The latest transaction was filed on 14 March 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations8 total
10,000 shares@ US$7.75080.011% mcap100.0% of flowCommon StockSEC:0001209191-22-018969:0
Ideal exit: 9 Dec 2022 (T+270)
18,750 sharesCommon StockSEC:0001209191-22-016856:0
13,750 shares0Common StockSEC:0001209191-22-006128:0
13,750 shares0Common StockSEC:0001209191-22-006128
26,091 shares0Common StockSEC:0001209191-22-000329:0
26,091 shares0Common StockSEC:0001209191-22-000329
104,662 shares0Common StockSEC:0001209191-21-057981
104,662 shares0Common StockSEC:0001209191-21-057981:0
8 of 8 declarations
About NEWELL WILLIAM J
William J. Newell is the CEO of Sutro Biopharma, Inc. He leads the company by overseeing its operations and developing strategies for innovation in the biopharmaceutical sector. His leadership is crucial for Sutro's growth.
